UBS Group’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-100
Closed -$7K 9237
2014
Q4
$7K Buy
+100
New +$6.57K ﹤0.01% 8712

Other funds holding PRLB

UBS Group's PRLB Position: Q1 2026 in Review

UBS Group reduced its Protolabs (PRLB) stake by 3.8% in Q1 2026, selling an estimated $387K and leaving 168,750 shares worth $9.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3396.

UBS Group first reported a position in PRLB in Q4 2014 and has held it in 46 quarters since. The position peaked at $9.68M in Q2 2025. 262 funds tracked by Wall St. Rank hold PRLB as of Q1 2026.

  • UBS Group held 168,750 shares of Protolabs worth $9.62M as of Q1 2026.
  • UBS Group sold 6,666 Protolabs shares in Q1 2026, an estimated $387K.
  • Protolabs made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3396 holding.
  • UBS Group first reported a position in Protolabs in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Protolabs position peaked at $9.68M in Q2 2025.
  • 262 funds tracked by Wall St. Rank held Protolabs as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.